Drug Shortage Report for CYESTRA-35
| Report ID | 107179 |
| Drug Identification Number | 02290308 |
| Brand name | CYESTRA-35 |
| Common or Proper name | Cyproterone acetate and ethinyl estradiol tablets |
| Company Name | PALADIN LABS INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | ETHINYL ESTRADIOL CYPROTERONE ACETATE |
| Strength(s) | 0.035MG 2MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 21 tabs blister |
| ATC code | G03HB |
| ATC description | ANTIANDROGENS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-02-20 |
| Estimated end date | 2020-04-02 |
| Actual end date | 2020-04-02 |
| Shortage status | Resolved |
| Updated date | 2020-04-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2020-04-03 | English | Compare |
| v6 | 2020-04-02 | French | Compare |
| v5 | 2020-04-02 | English | Compare |
| v4 | 2020-04-01 | French | Compare |
| v3 | 2020-04-01 | English | Compare |
| v2 | 2020-02-25 | French | Compare |
| v1 | 2020-02-25 | English | Compare |
Showing 1 to 7 of 7